 |
| © Provided by CNET Samsung's newest watch has ECG, but it's now FDA cleared for US use. Samsung |
The newest Samsung smartwatch, the Galaxy Watch 3, is striving for blood pressure and blood oxygen monitoring, even if those aren't ready for US markets yet. But, its ECG feature finally has FDA clearance.
Samsung announced that the on-wrist electrocardiogram on its newest Galaxy Watch 3 has FDA clearance, which is good news for anyone waiting on a Samsung watch with ECG to be useful in the US. The Samsung Galaxy Watch Active 2 added ECG last year, but didn't get FDA clearance.
Samsung's global PR confirmed the news on FDA clearance, but didn't confirm what timeframe the ECG features would arrive to US customers, or if/when those features will finally be unlocked for US users of the Galaxy Watch Active 2.
The newest Watch 3's blood pressure and oxygen monitoring features are currently only cleared for use in South Korea, and the blood pressure monitor requires calibration with a blood pressure cuff in order to use.
We'll update this story when we know more.
See more at: CNET
Samsung announced that the on-wrist electrocardiogram on its newest Galaxy Watch 3 has FDA clearance, which is good news for anyone waiting on a Samsung watch with ECG to be useful in the US. The Samsung Galaxy Watch Active 2 added ECG last year, but didn't get FDA clearance.
Samsung's global PR confirmed the news on FDA clearance, but didn't confirm what timeframe the ECG features would arrive to US customers, or if/when those features will finally be unlocked for US users of the Galaxy Watch Active 2.
The newest Watch 3's blood pressure and oxygen monitoring features are currently only cleared for use in South Korea, and the blood pressure monitor requires calibration with a blood pressure cuff in order to use.
We'll update this story when we know more.
